Showing results (31-40 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Rheumatic Diseases|September 3, 2013
Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritisSima Sh Farid, Gholamreza Azizi, Abbas Mirshafiey
Current Drug Discovery Technologies|December 28, 2019
β-D-Mannuronic Acid (M2000) as a Landmark in PharmacologyNada A G Gaafar, Alireza Razavi, Abbas Mirshafiey
International Immunopharmacology|October 3, 2021
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAsMona Aslani, Seyed Shahabeddin Mortazavi-Jahromi, Abbas Mirshafiey
Immunology Letters|July 22, 2021
Efficient roles of miR-146a in cellular and molecular mechanisms of neuroinflammatory disorders: An effectual review in neuroimmunologyMona Aslani, Seyed Shahabeddin Mortazavi-Jahromi, Abbas Mirshafiey
Drug Development Research|November 3, 2020
Evaluation of the oral administration of α-l-guluronic acid on COX-1 and COX-2 gene expression profile in ankylosing spondylitis patientsArezoo Sadoughi, Reza Mansouri, Sepideh Nazeri, et al.
Innovations in Clinical Neuroscience|October 23, 2014
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis TherapyAbbas Mirshafiey, Ghasem Ghalamfarsa, Babak Asghari, et al.
Iranian Journal of Allergy, Asthma, and Immunology|September 16, 2019
The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisAbdollah Jafarzadeh, Maryam Nemati, Hossain Khorramdelazad, et al.
Immunology Letters|August 19, 2020
A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseasesSeyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Abbas Mirshafiey
Immunopharmacology and Immunotoxicology|January 27, 2006
Artemether: a new therapeutic strategy in experimental rheumatoid arthritisSalvatore Cuzzocrea, Farshid Saadat, Rosanna Di Paola, et al.
Immunopharmacology and Immunotoxicology|May 31, 2021
Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cellMonireh Mohsenzadegan, Fatemeh Moghbeli, Abbas Mirshafiey, et al.
Pageof 20